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Introduction
The essential role of VEGF in blood vessel formation in
the embryo and in the adult is well established (1, 2). A
single VEGF gene gives rise, by alternative splicing, to
multiple isoforms (VEGF121, VEGF165, and VEGF189 in
humans versus VEGF120, VEGF164, and VEGF188 in the
mouse) that differ in molecular mass, solubility, and
receptor binding (3). VEGF120 lacks exons 6 and 7,
encoding extracellular matrix binding structures, and is
therefore the most soluble. VEGF188 contains all exons
and avidly binds to the cell surface and extracellular
matrix. VEGF164 lacks only exon 6 and has intermediate
properties. The VEGF isoforms bind to several recep-
tors: VEGFR-1 (Flt-1), VEGFR-2 (Flk-1), and neuropilin-
1 (NP-1) (3). NP-1 is a semaphorin receptor involved in
neuron guidance. As a VEGF164-specific coreceptor for
VEGFR-2, NP-1 also affects angiogenesis (4) and
enhances the angiogenic activity of VEGF164 (5).
To define the differential role of the VEGF isoforms
in vivo, mice expressing single VEGF isoforms were gen-
erated. Impaired myocardial angiogenesis has been
demonstrated in VEGF120/120 mice (expressing VEGF120)
(6). Here we report that loss of VEGF164 (in VEGF120/120
and VEGF188/188 mice) impaired retinal arterial develop-
ment, whereas loss of VEGF164 and VEGF188 (in
VEGF120/120 mice) led to dysregulated vessel outgrowth
and patterning in the retina. These observations suggest
possible mechanisms for the distinct roles of the VEGF
isoforms in retinal vascular patterning and arterial
endothelial cell specification.
Methods
Generation of transgenic mice. Targeted mutagenesis was
achieved by homologous and Cre/lox P–mediated site-
specific recombination in embryonic stem (ES) cells.
The strategy to generate VEGF120/120 mice (deletion of
exons 6 and 7) has been described previously (6). Tar-
geting vectors used to generate VEGF164/164 mice and
VEGF188/188 mice were constructed by replacing the
genomic sequence with a cDNA containing the fused
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The murine VEGF gene is alternatively transcribed to yield the VEGF120, VEGF164, and VEGF188
isoforms, which differ in their potential to bind to heparan sulfate and neuropilin-1 and to stimu-
late endothelial growth. Here, their role in retinal vascular development was studied in mice selec-
tively expressing single isoforms. VEGF164/164 mice were normal, healthy, and had normal retinal
angiogenesis. In contrast, VEGF120/120 mice exhibited severe defects in vascular outgrowth and pat-
terning, whereas VEGF188/188 mice displayed normal venular outgrowth but impaired arterial devel-
opment. It is noteworthy that neuropilin-1, a receptor for VEGF164, was predominantly expressed in
retinal arterioles. These findings reveal distinct roles of the various VEGF isoforms in vascular pat-
terning and arterial development in the retina.
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exons 4, 5, 7, and 8 (for VEGF164; Figure 1) or 4 to 8 (for
VEGF188). A lox P–flanked neomycin phosphotrans-
ferase (neo) cassette was placed in the 3′ UTR to allow
positive selection. After electroporation, recombinant
ES cell clones were identified by Southern blot analysis
of genomic DNA (6) and transfected with a Cre expres-
sion plasmid to excise the lox P–flanked neo cassette.
Cre-excised ES cell clones were used for diploid aggre-
gation, yielding VEGF+/188 mice. ES cell clones carrying
a mutant VEGF164 allele and neo were used for diploid
aggregation, and the resulting germline mice were
intercrossed with a mouse line expressing the Cre trans-
gene under the activity of the phosphoglycerokinase
(PGK) promoter to achieve in vivo excision of the neo
cassette. The resulting VEGF+/164 or VEGF+/188 mice were
bred to homozygosity. Genotyping was done by PCR
using the following primers (in exon 5 and 7, respec-
tively): 5′ CCAAAGAAAGACAGGACAAAGCCAGAA 3′ and
5′ GCAAGTACGTTCGTTTAACTCAAGCTG 3′, resulting in
PCR products of greater than 2 kb, 170 bp, and 230 bp
in VEGF+/+, VEGF164/164, and VEGF188/188 mice, respec-
tively. VEGF isoform-specific mice were intercrossed
with mice expressing a β-galactosidase (LacZ) gene
under an ephrin-B2 promoter (7), a Tie1 promotor (8),
or a promoter specific for pericytes and vascular
smooth muscle cells (9).
Histology, whole-mount in situ hybridization, and retinal
trypsin digest. All methods for immunohistochemistry
and LacZ staining have been described (6, 7, 10).
Endothelial cells, vascular smooth muscle cells, and
astrocytes, were labeled with biotinylated Bandeiraea sim-
plicifolia (BS-1) Isolectin (L3759; Sigma-Aldrich NV/SA,
Bornem, Belgium) or anti-CD31 (557355; BD Bio-
sciences, Erembodegem, Belgium), anti–α-smooth mus-
cle actin (labeled with FITC; F3777, Sigma-Aldrich
NV/SA), and antiglial fibrillary acidic protein (Z0334;
Dako SA, Trappes Cedex, France), respectively. Retinas
were scanned with a Zeiss laser scanning microscope
(LSM 510; Carl Zeiss Jena GmbH, Jena, Germany). For
triple immunostainings, markers were combined with
anti–VEGFR-1 (MF1) or anti–VEGFR-2 antiserum (457-
683; both from ImClone Systems Inc., New York, New
York, USA), or rabbit anti–NP-1 antiserum (provided by
H. Fujisawa, Department of Molecular Biology, Nagoya
University, Nagoya, Japan; ref. 11). For electron
microscopy, specimens were processed as described pre-
viously (6) and imaged on a Hitachi H7000 electron
microscope. Whole-mount in situ hybridization was
performed as described (12). The probes for ephrin-B2
and PDGFRβ were a gift from R. Klein, Department of
Ophthalmology and Visual Sciences, University of Wis-
consin Medical School, Madison, Wisconsin, USA (12)
and C. Betsholtz, Department of Medical Biochemistry,
Goteborg University, Goteborg, Sweden (13), respec-
tively. The templates for NP-1 were obtained by reverse
transcription of RNA from 6-day-old mouse retinae and
PCR amplification of specific gene fragments using
nested primer pairs (5′ CCAAGCTCCGGAACCCTACCA 3′,
5′ CCTTGCGCTTGCTGTCATCCAT 3′, 5′ TCAGAACTAT-
ACAGCACCTACT 3′, 5’ TGAATGATGACACCTCTTACTA 3′).
Immunolabeling with anticollagen type IV (Biogenesis
Ltd., Poole, United Kingdom) was performed after in
situ hybridization. Pericyte density was determined on
pepsin-trypsin–digested preparations (14) and
expressed per retinal area. The endothelial to pericyte
ratio was quantitated using retinal image analysis.
Results
Targeting of VEGF isoform-specific alleles. The VEGF gene is
alternatively spliced to the VEGF120 isoform (lacking
exon 6 and 7), the VEGF164 isoform (lacking exon 6),
and the VEGF188 isoform (encoded by all eight exons).
Generation of mice selectively expressing single VEGF
isoforms was achieved by Cre/lox P–mediated recombi-
nation in ES cells, using a “knock-in” strategy (see
Methods; Figure 1). Quantitative RT-PCR analysis of
brain RNA confirmed the selective expression of the
respective VEGF isoform transcripts in each of these
genotypes. Only the VEGF164 isoform was detected in
VEGF164/164 mice (340 ± 46 VEGF164 mRNA copies per
1,000 hprt copies, mean ± SD, n = 5) and the VEGF188 iso-
form in VEGF188/188 mice (770 ± 210 VEGF188 transcript
copies per 1,000 hprt copies, n = 5), while the other iso-
forms were undetectable (<0.3 VEGF164 or VEGF188
copies per 1,000 hprt copies). Total VEGF transcript lev-
els of the VEGF isoforms were comparable to those in
VEGF+/+ mice (total VEGF mRNA copies per 1,000 hprt
copies: 250 ± 99 in VEGF+/+, 230 ± 75 in VEGF164/164, and
400 ± 120 in VEGF188/188 mice; n = 5, P = not significant
[NS]); the data in the VEGF120/120 mice have been report-
ed previously (6).
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Figure 1
Targeting strategy. Modification of the VEGF gene to generate the
VEGF 164 targeting vector. Top: Targeting vector pPNT.VEGF 164 and
wild-type VEGF allele (VEGF WT). Middle: Homologously recombined
VEGF 164 allele (VEGF164neo). Bottom: Modified VEGF 164 allele after Cre
excision of the lox P–flanked neo cassette.
Inheritance and viability of VEGF-isoform mice. VEGF+/120,
VEGF+/164, and VEGF+/188 mice were normal, healthy,
and had a normal life span. Offspring of VEGF+/120
breeding pairs were born at a normal Mendelian fre-
quency, but half of VEGF120/120 neonates died shortly
after birth because of cardiorespiratory distress (6). The
other VEGF120/120 mice died within 2 weeks after birth,
in part due to impaired myocardial angiogenesis result-
ing in cardiac failure (6).
VEGF164/164 mice were born at a normal Mendelian fre-
quency. Of 366 live neonates born from VEGF+/164 breed-
ing pairs, 25% were VEGF+/+, 51% were VEGF+/164, and
24% were VEGF164/164. They gained weight normally 
(32 ± 6 g in VEGF+/+ mice, n = 8, versus 32 ± 4 g in
VEGF164/164 mice, n = 23, at 7 weeks; P = NS), were fertile
(litters per breeding pair during 4 months: 4.8 ± 1.3 for
VEGF+/+ mice, n = 4, versus 4.8 ± 0.5 for VEGF164/164 mice,
n = 4; P = NS), and produced litters with normal size 
(11 ± 3 pups for VEGF+/+ litters, n = 35, versus 10 ± 3 for
VEGF164/164 litters, n = 58; P = NS).
VEGF188/188 mice were underrepresented at birth; out
of 73 live-born pups, 24% were VEGF+/+, 64% were
VEGF+/188, and only 12% were VEGF188/188, indicating that
a fraction of the VEGF188/188 mice died in utero (P < 0.05
for observed vs. expected). Surviving VEGF188/188 mice
gained less weight than VEGF+/+ mice at 7 weeks of age
(32 ± 6 g in VEGF+/+ mice, n = 8, versus 22 ± 3 g in
VEGF188/188 mice, n = 16; P < 0.05). VEGF188/188 breeding
pairs were less fertile (number of litters per breeding pair
during 4 months: 4.8 ± 0.5 for VEGF+/+ mice, n = 4, ver-
sus 3.7 ± 0.6 for VEGF188/188 mice, n = 3; P < 0.05) and had
smaller litter sizes (11 ± 3 pups for VEGF+/+ litters, n = 35,
versus 7 ± 2 pups for VEGF188/188 litters, n = 53; P < 0.05).
Retinal vascular development in wild-type mice. Retinal vas-
cularization was monitored by immunostaining of
whole-mount preparations for CD31/PECAM or lectin
for endothelial cells (ECs), smooth muscle alpha actin
(SMA) for vascular smooth muscle cells (vSMCs) and
pericytes (PCs), and GFAP for astrocytes (ACs). To study
recruitment of periendothelial cells (PECs), VEGF-iso-
form mice were intercrossed with mice expressing LacZ
in PECs (PECLacZ mice) (9). Arterial specification of ECs
was examined by in situ hybridization for ephrin-B2
and by intercrossing VEGF isoform mice with mice har-
boring a LacZ gene under the control of the endogenous
ephrin-B2 promoter (EB2LacZ mice) (7).
The Journal of Clinical Investigation | February 2002 | Volume 109 | Number 3 329
Figure 2
Retinal vascular development in VEGF+/+ and VEGF164/164 mice. (a) PECAM staining in VEGF+/+ at P5. Capillaries reach two-thirds to three-
quarters of the retinal radius. Arterioles (A) are thin and have a capillary-free zone. Venules (V) are broader and lack a capillary-free zone.
La, arteriolar length; Lv, venular length; Lr, radius of retina; Lva, radius of vascular bed. (b and c) In situ hybridization for ephrin-B2 (EB2)
(b) with or (c) without collagen type IV fluorescent immunostaining on VEGF+/+ retina at P5 (EB2/CollIV). EB2 expression is confined to
morphologically defined arterioles (see above) and extends into arterial capillaries (arrows). (d and e) Triple staining with LacZ (in PECs,
blue dots), lectin (in ECs, red), and anti-SMA (in vSMCs, green) on a VEGF+/+ × PECLacZ P5 retina (LacZ/Lec/SMA). (d) PECs have spread
along all retinal vessels, whereas (e) only arterioles are SMA positive. (f) EM of VEGF+/+ capillary at P5, which appears constricted. (g) PECAM
staining on VEGF+/+ P9 retina. (h) SMA staining in VEGF+/+ at P14 is confined to arterioles and their side branches. (i) VEGF+/+ × PECLacZ reti-
na at 4 weeks. Hyaloid arteries (HA) have regressed (HA remnant, arrow). (j) Double staining for lectin (red) and GFAP (in ACs, green)
(Lec/GFAP). AC network in front of vasculature. (k) PECAM staining of VEGF164/164 retina at P5. Normal vascular development.
Before birth, the murine retina is avascular and
receives oxygen from the hyaloid and choroidal vessels.
Postnatally, the increased retinal thickness and metab-
olism cause physiological hypoxia, which upregulates
VEGF expression and initiates outgrowth of vessels
from the optic disc (10). This results in the formation of
a uniform capillary-like vascular labyrinth by postnatal
day 2 (P2), which covers approximately 40% of the reti-
na (not shown). Analysis of PECLacZ mice revealed that
these primitive vessels were already covered by PECs,
which, however, did not express SMA (not shown).
Using whole-mount in situ hybridization, ephrin-B2
was detectable in 50% of the retinal vessels (e.g., in
future arterioles) in an alternating pattern (not shown),
indicating that arteriovenous specification had already
occurred at this early stage of vascular development.
By P5, the vascular bed covered approximately 70%
of the retina and had remodeled into a more mature
network of branching vessels, which could be mor-
phologically distinguished as arterioles, venules, and
capillaries (Figure 2a). Arterioles had a small lumen
and were surrounded by a capillary-free zone (a result
of capillary pruning), whereas venules were wider and
embedded in capillary-rich regions. Ephrin-B2 was
expressed in retinal arterioles but not in venules (Fig-
ure 2, b and c). Analysis of PECLacZ mice revealed that
PECs had spread along all vessels (Figure 2d), whereas
expression of SMA was detectable in larger arterioles
but not in venules or capillaries (Figure 2e). Transmis-
sion electron microscopy (EM) confirmed the presence
of PCs along the retinal capil-
laries, which contracted dur-
ing fixation (Figure 2f).
By P9, the vascular network
had reached the periphery of
the retina (Figure 2g). Arteri-
oles and venules grew out over
88% ± 4% and 79% ± 6% of the
retinal radius, respectively
(Table 1). Venules were larger
than arterioles, whereas capil-
laries had the smallest lumen
(Table 1). On average, between
five and six arterioles and
venules were present per retina
(Table 1). PECs covered arteri-
oles, venules, and capillaries,
resulting in a capillary EC-to-
PC ratio (EC/PC ratio) of 5:1
(Table 1). However, only the
primary and secondary side
branches of arterioles ex-
pressed detectable SMA levels,
while the venules and capillar-
ies remained negative at P9
and beyond (Figure 2h).
The hyaloid vasculature is
present during development,
but regresses once the devel-
oping retinal vasculature provides sufficient oxygen to
the retina (15) (Figure 2i). Consistent with previous
findings that the hyaloid vasculature contains only
arteries (15), all hyaloid vessels in EB2LacZ mice
expressed ephrin-B2 (not shown). Hyaloid vessels were
adjacent to the retina at P0 but did not make contact
with retinal vessels and could easily be peeled away
from the retina upon dissection of the retina from P0
up until their regression. They showed signs of regres-
sion by P9 and had disappeared by 4 weeks (Figure 2i).
Astrocyte development (ACs) have been implicated in
guiding vessel outgrowth by producing a VEGF gradi-
ent (10). Whole-mount double immunofluorescent
staining for GFAP and lectin revealed that spindle-
shaped ACs were spreading across the avascular retina
at P0.5 and had reached the periphery of the retina by
P2–3 (not shown). ACs in these avascular regions
expressed abundant VEGF (not shown). At later times
they became organized into a network of tubes
wrapped around outgrowing vessels (Figure 2j). Once
the vasculature had reached the retinal periphery
(P9),VEGF expression in the central vascularized
regions was minimal.
Normal retinal vascular development in VEGF164/164 mice.
In VEGF164/164 mice, the formation of a primitive
labyrinth and subsequent remodeling was indistin-
guishable from that in VEGF+/+ mice, resulting in simi-
lar numbers and sizes of arterioles, venules, and capil-
laries by P5 (Figure 2k, Table 1). Arterioles grew out
over 89% ± 10%, capillaries over 99% ± 5%, and venules
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Table 1
Characteristics of retinal vessels in VEGF-isoform mice
VEGF+/+ VEGF120/120 VEGF164/164 VEGF188/188
Arterioles
Number of arterioles/retina 5.7 ± 1.0 3.1 ± 0.3A 5.2 ± 1.0 2.8 ± 1.5A
La (% of Lr) 88 ± 2 35 ± 9A 89 ± 10 18 ± 13A
La (% of Lva) 88 ± 2 53 ± 6A 90 ± 6 18 ± 13A
Width (µm) 47 ± 8.3 41 ± 9.8 46 ± 3.5 22 ± 0.4A
Number of PECs/mm artery 23 ± 0.9 19 ± 2A 24 ± 2 16 ± 2A
Number of vessels with capillary-free zone 5.7 ± 1.0 3.1 ± 0.3A 5.2 ± 1.0 2.8 ± 1.5A
SMA immunoreactivity ++ + ++ +
Venules
Number of venules per retina 5.4 ± 1.0 3.1 ± 0.3A 5.1 ± 1.0 5.7 ± 1.2
La (% of Lr) 79 ± 1 52 ± 12A 80 ± 3 76 ± 6
La (% of Lva) 81 ± 1 80 ± 4 81 ± 12 79 ± 6
Width (µm) 69 ± 2 76 ± 15 71 ± 15 74 ± 9
Number of PECs/mm venule 17 ± 2 14 ± 4 19 ± 2 19 ± 2
SMA immunoreactivity – + – +
Capillaries
Number/mm2 190 ± 18 240 ± 27A 180 ± 21 310 ± 21A
Width (µm) 19 ± 1.7 29 ± 4.2A 18 ± 1.6 20 ± 2.1
PECs/mm2 51 ± 1 39 ± 6A 51 ± 3 60 ± 3A
EC vs. PC ratio 5.3 ± 0.2 16 ± 4A 6.5 ± 4 7.2 ± 1.4
SMA immunoreactivity – + – +
Lva (% of Lr) 99 ± 0.5 65 ± 12A 99 ± 3 99 ± 1
The data represent the mean ± SD of 3 to 13 retinas at P9. Lengths of the arterioles and venules, as well as
capillary outgrowth, are expressed as a percentage of the radius of the retina (La/Lr, Lv/Lr, Lva/Lv, respec-
tively) and as a percentage of the radius of the vascular bed (La/Lva and Lv/Lva, respectively; Figure 2a). The
diameter of the vessels is expressed in micrometers, the number of PCs along arterioles and venules in num-
ber per millimeter and per retinal area that is covered with capillaries (number/mm2). AP < 0.05 vs. control
(VEGF +/+). La, arteriolar length; Lv, venular length; Lr, radius of retina; Lva, radius of vascular bed.
over 80% ± 12% of the retinal radius (Table 1). Ephrin-
B2 and SMA expression (not shown), as well as PEC
numbers and EC/PC ratios (Table 1), hyaloid regres-
sion, AC accumulation, and VEGF expression were
comparable to VEGF+/+ at all ages (not shown).
Impaired retinal arterial development in VEGF188/188 mice.
Retinal vessels. In mice expressing only VEGF188, a nor-
mal capillary labyrinth containing PECs (not yet express-
ing SMA) developed by P3 (not shown). By P5, only half
of the normal number of large vessels was present. These
were morphologically identified as venules (Figure 3a),
did not express ephrin-B2 (Figure 3, b and c), and failed
to stain for SMA (Figure 3e), although PECs were pres-
ent (Figure 3d), which contracted upon fixation (Figure
3f). At P6, ephrin-B2 was detectable in rudimentary reti-
nal arterioles, suggesting that arterial specification was
not lost (inset in Figure 3c). At P9, only half of the nor-
mal number of arterioles developed, grew out over only
17% ± 13% of the retina and were smaller in size (Table 1;
Figure 3g). They were also covered by fewer LacZ-positive
PECs (Table 1), which stained faintly for SMA at P9 and
P14 (Figure 3h). In contrast to the arterial defects,
venous and capillary development appeared largely nor-
mal. On average, there were five to six venules per retina,
which grew out normally (Figure 3, a and g; Table 1),
while capillaries grew out over 99% ± 2% of the retina at
P9 (Table 1). The venules were somewhat enlarged and
covered by PECs, which were positive for SMA (Figure
3h), possibly due to the arterial underdevelopment and
resultant abnormal retinal perfusion. In addition, capil-
lary pruning was decreased, resulting in a more dense
capillary bed and a slight increase in the number of PECs
per retinal area (Table 1; Figure 3, d and e), but in a nor-
mal EC/PC ratio (Table 1).
Hyaloid vessels could not be easily dissected away
from the retina and had established numerous con-
nections with the retinal vascular network at P5. By P9,
several hyaloid vessels had migrated into peripheral
retina and established an arterial network (Figure 3g).
Hyaloid arteries persisted up to 4 weeks of age (Figure
3i) and penetrated the inner limiting membrane distal
to the site of maximal outgrowth of the rudimentary
arterioles in the midretina (Figure 3, i and j). Possibly,
the hyaloid vessels infiltrated the retina in response to
the increased VEGF expression (not shown) that
occurred as a result of insufficient arterial supply,
thereby salvaging the hypoperfused periphery.
ACs migrated out normally to the retinal periphery
by P2 (not shown) and had remodeled into a network
that preceded the outgrowing vessels at P5 (Figure 3k).
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Figure 3
Retinal vascular development in VEGF188/188 mice. (a) PECAM staining at P5. Capillary outgrowth comparable to VEGF+/+ retinas, but no
morphologically defined arterioles. (b and c) EB2/CollIV at P5. No EB2 expression at P5. Inset in c: VEGF188/188 × EB2LacZ retina at P6 shows
small ephrin-B2–positive vessel (arrow). (d and e) LacZ/Lec/SMA on a VEGF188/188 × PECLacZ retina at P5, revealing (b) high PC density, (c)
but no SMA immunoreactivity. (f) EM at P5 shows normal capillary constriction. (g) PECAM staining at P9 with increased capillary densi-
ty in the midperipheral retina (arrow) and partially removed hyaloid arteries. (h) SMA immunoreactivity is attenuated in arterioles, but has
become positive in venules and capillaries (arrow) at P14. (i and j) VEGF188/188 × PECLacZ retina at 4 weeks. (i) Persistence of hyaloid arteries
and underdevelopment of arterioles. (j) Same retina after dissection of hyaloid arteries. Central part, but not peripheral part (arrows), of
hyaloid arteries can be removed. (k) Lec/GFAP. ACs are organized into a tubular network well in front of the vascular bed.
At P9, ACs accumulated in increased numbers at sites
where hyaloid vessels made connections to the retinal
vascular bed (not shown).
Impaired vascular outgrowth in VEGF120/120 retinas. Severe
retinal vascular defects were detected in VEGF120/120
mice. Only a primitive vascular labyrinth of capillary-
like vessels with uniform size developed by P5 (Figure
4a). Even though arteries and veins could not be mor-
phologically distinguished, 50% of the retinal vessels
expressed ephrin-B2 (Figure 4, b and c), suggesting that
arteriovenous specification occurred before the remod-
eling stage. PEC recruitment was delayed; only scat-
tered PECs were detected in and around the optic disc
(Figure 4d), and retinas were still SMA negative at P5
(Figure 4e). EM illustrated that the sparsity of the PC
resulted in a relaxed appearance of capillaries upon fix-
ation (Figure 4f), as in diabetic retinopathy associated
with PC dropout.
In contrast to the other genotypes, the capillary bed
in VEGF120/120 mice covered the retina only over two-
thirds in the small fraction of VEGF120/120 mice that sur-
vived until P9 (Table 1). The vascular network had par-
tially remodeled into morphologically recognizable
arteries, capillaries, and veins (Figure 4g). To distin-
guish between a nonspecific general vascular defect and
a specific arteriolar defect, outgrowth of arterioles was
expressed as a percentage of the radius of the retina as
well as the vascular bed. Arterial development was most
significantly impaired; less than half of the number of
arterioles grew out over only 35% of the retina and 53%
of the vascular bed (Table 1; Figure 4g). Only half of the
number of venules could be morphologically identified
in VEGF120/120 mice at P9, but venules had a normal
lumen size and grew out over only 52% of the retinal
radius, but over 80% of the vascular bed (Table 1; Fig-
ure 4g). There were more numerous and dilated capil-
laries in the central retina (Table 1). Fewer PECs sur-
rounded the arterioles, venules, and capillaries,
resulting in an increased EC/PC ratio (Table 1). The
impairment was also reflected by a fragility of the cap-
illaries, causing hemorrhages (Figure 4k). Possibly
because of the increased hemodynamic stress, these
PECs stained somewhat more strongly for SMA (Figure
4h). VEGF expression was markedly upregulated in the
avascular retina, suggesting that the peripheral retina
was highly ischemic (not shown).
No signs of hyaloid regression were observed in
VEGF120/120 mice at P9, and the hyaloid vessels
appeared dilated and tortuous (Figure 4i). However,
unlike in VEGF188/188 mice, the hyaloid arteries in
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Figure 4
Retinal vascular development in VEGF120/120 mice. (a) PECAM staining at P5. Dramatic impairment of vascular outgrowth. Arterioles and
venules are morphologically indistinguishable. (b and c) EB2/CollIV at P5. Clusters of EB2-positive and -negative vessels alternate. (d and
e) LacZ/Lec/SMA on VEGF120/120 × PECLacZ retina at P5. (d) Sparse blue cells near optic disc. (e) SMA immunoreactivity is undetectable. (f)
EM at P5 shows capillary relaxation. (g) PECAM staining at P9 with more pronounced impairment in arteriolar than venular outgrowth. (h)
Arterial SMA staining is fainter, while venules and capillaries have become strongly SMA positive at P14. (i) VEGF120/120 × Tie1LacZ retina at
P9, with persisting dilated and tortuous hyaloid arteries. (j) Lec/GFAP. AC organization into a network is present in the vascularized area,
but rapidly alters to the primitive bipolar shape and parallel organization in the more peripheral retina (arrow). (k) Unstained whole-mount
preparation at P9 with retinal hemorrhages (arrows).
VEGF120/120 mice neither penetrated the retina nor
made connections with the retinal vasculature.
ACs initially migrated normally out to the periphery
of the retina (not shown). By P5 and P9, ACs in the cen-
tral vascularized retina associated with retinal vessels
showed strong GFAP expression. In the avascular reti-
nal periphery, however, GFAP immunoreactivity was
weak (Figure 4j), possibly due to tissue damage sec-
ondary to the ischemia. VEGF expression was more
abundant at the edge of the vascular bed, likely the
result of local hypoxia (not shown).
Expression of VEGF receptors. Whole-mount in situ
hybridization of retinas from VEGF+/+ pups at P5 and P9
revealed that NP-1 was expressed in retinal arterioles
and, at a much lower level, in retinal venules (Figure 5a).
Higher magnification suggested that NP-1 is expressed
in ECs (Figure 5b) and likely also in PECs (Figure 5, b
and c), which were also labeled for PDGF receptor-β
(Figure 5d). NP-1 mRNA expression has been reported
previously in ECs and PECs (16). By triple immunoflu-
orescent staining for NP-1, lectin, and SMA, NP-1 was
detectable in retinal neurons, but not in ECs or PECs in
the retina (Figure 5, e and f). Immunostaining for
VEGFR-1 or VEGFR-2 indicated that VEGFR-1 was
expressed in ECs and vSMCs of arteries and veins (Fig-
ure 5, g and h), whereas VEGF-R2 was expressed only in
ECs of capillaries and venules in the retina (Figure 5, i
and j), brain, heart, and kidney (not shown). Specificity
of the VEGFR-1 and VEGFR-2 staining has been report-
ed elsewhere (17). Expression of VEGFR-1 (18) and 
NP-1 (19) has been documented previously in PECs.
Arterial development in other organs. A similar number of
glomerular arterioles was present in anti-SMA–stained
sections of VEGF+/+, VEGF164/164, and VEGF188/188 kidneys
(arterioles per kidney section: 45 ± 2, 49 ± 9, and 42 ± 7,
respectively; n = 5; P = NS). Comparable densities of
small, medium, and large coronaries were found in
VEGF+/+ (vessels per square millimeter: 8.5 ± 2.9, 4.3 ± 1.0,
and 3.4 ± 1.6; n = 6), VEGF164/164 (vessels per square mil-
limeter: 8.1 ± 3.1, 4.2 ± 2.0, and 3.5 ± 1.8; n = 4, P = NS),
and VEGF188/188 hearts (vessels per square millimeter: 
9.6 ± 2.8, 6.2 ± 2.6, and 2.5 ± 1.7; n = 6, P = NS). VEGF120/120
mice had fewer renal and coronary arteries (6).
Discussion
The present study investigates the distinct role of the
different VEGF isoforms in retinal vascular develop-
ment. Retinal vascular development was normal in
VEGF164/164 mice, indicating that this isoform contains
all necessary information for normal outgrowth and
remodeling of blood vessels. In contrast, VEGF120/120
mice exhibited severe vascular defects, with impaired
venous and severely defective arterial vascular develop-
ment in the retina. VEGF188/188 mice had normal venous
development, but aborted arterial outgrowth.
Role of the VEGF isoforms in endothelial outgrowth. Astro-
cytes migrate in front of ECs and guide them to the
periphery of the retina by releasing VEGF (20). Out-
growth of the vascular bed was normal in VEGF164/164
and VEGF188/188 mice (except for the arterioles in
VEGF188/188 retinas). In contrast, in VEGF120/120 mice
there was a defect in EC outgrowth, affecting all vessel
types. This may be due to the fact that VEGF120 is less
potent in inducing EC mitosis (21) or has reduced
affinity for VEGFR-1 (22), which could affect EC func-
tion or survival (6). Alternatively, VEGF164 and
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Figure 5
VEGF receptor expression in VEGF+/+ retinas. (a)
Whole-mount in situ hybridization for NP-1 at
P5. Expression is prominent in arterioles and dis-
crete in venules. (b) In situ hybridization on reti-
nal sections at P7 is suggestive of NP-1 expres-
sion in ECs as well as PECs (arrows). (c and d)
High magnification of whole-mount in situ
hybridization for (c) NP-1 and (d) PDGF recep-
tor-β (PDGFRβ) illustrates that PECs are positive
for PDGFRβ and suggest NP-1 expression in
PECs (arrows). (e and j) Fluorescent triple
immunostaining using lectin, anti-SMA, and
anti-VEGFR on sections from VEGF+/+ eyes at P9.
Lectin (blue), VEGFR (red), and SMA (green). (e
and f) NP-1 is detectable in retinal neurons
(arrowheads), but its expression is beyond the
detection limit in vessels by immunostaining. (g
and h) VEGFR-1 (R1) is expressed in vSMCs as
well as ECs (arrow). (i and j) VEGFR-2 (R2)
expression is only detectable in the ECs (arrows)
in capillaries and venules.
VEGF188, in binding the extracellular matrix, may pro-
vide matrix-associated guidance cues that facilitate EC
migration through the retina, possibly through the
establishment of a VEGF gradient or “trail” along
which ECs migrate. Such cues would likely be absent in
VEGF120/120 mice in which diffusion of the soluble
VEGF120 isoform would induce random EC migration.
These hypotheses are consistent with the finding that
VEGF120-expressing tumors are hypovascular, in con-
trast to VEGF164- or VEGF188-expressing tumors (23).
This would implicate an important role for the differ-
ent VEGF isoforms in correct patterning of nascent ves-
sels. Vessel patterning is an essential characteristic of
normal angiogenesis, which remains poorly under-
stood at the molecular level.
Role of the VEGF isoforms in retinal arterial development.
Genotype-specific defects were observed in the forma-
tion of retinal arterioles and venules. In VEGF+/+ and
VEGF164/164 mice, arterioles reached out over approxi-
mately 90% of the entire vascular bed at P9. In
VEGF120/120 mice, there were fewer and smaller venules
and arterioles but, whereas venules reached out over
80%, arterioles extended over only approximately 50%
of the vascular bed. Arteriolar defects were even more
pronounced in VEGF188/188 mice, in which arterioles
(but not venules) were smaller and extended over only
18% of the vascular bed. Thus, the VEGF164 isoform is
sufficient for venular and arteriolar development, the
VEGF188 isoform allows venular but not arteriolar
development, and the VEGF120 isoform is insufficient
for venular, but especially for arteriolar, development.
Arterial EC specification. The current hypothesis sug-
gests that “arterialization” of an undifferentiated vas-
cular network requires remodeling and recruitment of
vSMCs in response to hemodynamic forces (reviewed
by ref. 24). More recent studies proposed that arterial
and venous ECs are molecularly distinct from the ear-
liest stages of vascular development, distinguishable
by their expression of gridlock (25), D114 (26), Bmx
(27), NP-1 (16), ephrin-B2 (on arterial ECs) and its
receptor Eph-B4 (on venous ECs) (7), and activin
receptor-like kinase-1 (28). Consistent with this
revised model, ephrin-B2 was expressed in half of the
vessels in VEGF+/+ and VEGF164/164 mice, even before
arterioles could be morphologically distinguished.
Since ephrin-B2 was also expressed in unremodeled
retinal vessels in VEGF120/120 mice, the impaired arteri-
olar development was not attributable to an aborted
arteriolar EC specification. In contrast, ephrin-B2
expression in VEGF188/188 mice was delayed until P6,
when rudimentary arterioles began to grow out, indi-
cating that these ECs were arterially differentiated but
failed to grow out normally. Whether defective arteri-
al outgrowth in VEGF188/188 mice resulted from
delayed or impaired arterial specification of EC pre-
cursors and/or outgrowth of arterial ECs, and why the
VEGF120 and VEGF164 isoforms are more efficient
than VEGF188 in inducing arterial specification
and/or outgrowth, remain to be determined. Intrigu-
ing possibilities are that the short isoforms induce
expression of arterial markers (as demonstrated for
Bmx) (27) or affect angioblasts even at an earlier stage
or that the VEGF188 isoform might be unable to pro-
vide spatial guidance or differentiation cues for reti-
nal arteriolar ECs because it remains associated with
the extracellular matrix.
PEC recruitment. PEC recruitment was normal in
VEGF164/164 mice. In contrast, VEGF120/120 mice exhibit-
ed generally impaired PEC recruitment resulting in
capillary dilatation and extravasation of red blood
cells, as described in the hearts of these mice (6), as
well as in other conditions of PEC dysfunction or
dropout (29). ECs release signals (such as PDGF-BB)
essential for PC recruitment (10). Since expression of
PDGF-BB is reduced in VEGF120/120 mice (6), it is pos-
sible that the impairment of PEC recruitment is
attributable to the general endothelial defects in
VEGF120/120 mice. Interestingly, VEGFR-1 was
expressed in retinal (as well as renal, brain, and car-
diac) arteriolar and venular PECs (this study and ref.
18), indicating that VEGF may have direct effects on
PC recruitment (10). Since the VEGF120 isoform binds
with a lower affinity to VEGFR-1 than the VEGF164
isoform (22), this short isoform may be unable to
recruit PECs as efficiently as the other isoforms.
VEGF188/188 mice, on the other hand, showed normal
PEC recruitment to venules and capillaries, but
reduced coverage of underdeveloped retinal arterioles.
This may again suggest that the impaired PC recruit-
ment is secondary to abnormal EC function in the
underdeveloped arterioles. Alternatively, diffusion of
the smaller VEGF isoforms may be essential for
chemoattracting VEGFR-1–positive PECs. The specif-
ic defect of PC recruitment around arterioles may also
suggest an essential interaction of the VEGF164 iso-
form with NP-1, which is more abundantly expressed
in retinal arterioles than in venules. Although not yet
described, the VEGF188 isoform likely binds to NP-1
since it contains exon 7, encoding the essential amino
acid residues for such interaction (30). Perhaps this
long isoform (which binds to the matrix) is unable to
reach the NP-1 receptor on PECs or impairs PC migra-
tion because it immobilizes the NP-1–positive PCs at
the site of VEGF188 production. A role for NP-1 in cell
adhesion has been suggested previously, although the
nature of the ligand remains unknown (31). Another
possibility is that blood flow in the underdeveloped
arterioles is abnormal, which could impair their mat-
uration. Finally, the retinal phenotype may have been
influenced by the impaired angiogenesis in the heart,
bone, and lungs of VEGF120/120 mice (6, 32, 33), the
growth retardation in the VEGF188/188 mice, or the rel-
ative overexpression of a single isoform. Indeed, each
of these knock-in mice expressed a single isoform at a
level comparable to the total expression of the three
isoforms in VEGF+/+ mice (this study and ref. 6). How-
ever, it is unlikely that the retinal phenotype was only
secondary to impaired vascular growth in other
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organs, because no such specific arterial defects were
detected in other organs.
Arterial development in other organs. While it may be a
surprise that this long isoform has a restricted role in
establishing arterioles in the retina, emerging evidence
indicates that the mechanisms of vessel formation (34),
as well as the differential expression of the VEGF iso-
forms (32), are highly dependent on the tissue microen-
vironment. Noteworthy in this context is that retinal
PECs are derived from neural crest cells, whereas PECs
in other tissues are derived from other sources (35).
Role of VEGF isoforms in the regression of hyaloid vessels. In
VEGF188/188 mice, the retinal arteriolar underdevelop-
ment prompted ingrowth by hyaloid arteries, which
established connections with the retinal vascular net-
work. In contrast, hyaloid vessels in VEGF120/120 mice
did not enter the retina, but were dilated and tortuous.
The dissimilarity in hyaloid vessel phenotype may be
attributable to the difference in solubility between the
VEGF isoforms. VEGF188 is matrix bound and pre-
sumably remains associated within the retina. Since
hyaloid vessels lie closely apposed to the retina, the
increased VEGF188 levels might attract these hyaloid
vessels into the ischemic peripheral retina (Figure 1g).
Alternatively, VEGF188 can be proteolytically cleaved
into a shorter, soluble isoform, which would establish
a VEGF gradient attracting hyaloid vessels (36). Solu-
ble VEGF120 would be expected to diffuse into the vit-
reous cavity (Figure 1f), explaining why hyaloid vessels
persisted, became dilated and tortuous, and failed to
enter the retina. Whether binding of VEGF188 to NP-1
mediates adhesion of hyaloid vessels to the retina
remains to be determined.
The persistence of hyaloid vessels in mice lacking
the VEGF164 isoform resembles the persistent hyper-
plastic primary vitreous disorder in humans, a com-
mon blinding congenital anomaly resulting from a
failure of hyaloid vessel regression (37). Taken
together, these findings suggest a novel role for the
various VEGF isoforms in endothelial outgrowth and
arterial development.
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